The New EU Medical Device regulation Global Compliance Panel
Delivery Method
Seminar
Target Audience Clinical Trial Managers, Regulatory Affairs, Medical Officers
Summary This Seminar will look at what to expect when the new regulation is implemented. Including: the transition period, Effect on Notified Bodies, Impact of the MDR on Quality Management Systems (QMS), technical documentation, clinical trial requirements, UDI and combination products.
Description/Agenda
Overview:
-
Regulation proposals of the European Commission Background
In 2012, the Commission adopted a package of measures on innovation in health. The package consisted of a Communication and two regulation proposals to revise existing legislation on general medical devices and in vitro diagnostic medical devices. In particular, the Directives on active implantable medical devices (90/385/EEC) and on medical devices (93/42/EEC) are intended to be replaced by a Regulation on medical devices, while the Directive on in-vitro diagnostic medical devices (98/79/EC) is intended to be replaced by a Regulation on the same subject.The revisions therefore affected all kinds of medical devices including in vitro diagnostic medical devices, from home-use items like sticking plasters, pregnancy tests and contact lenses, to X-ray machines, pacemakers, breast implants, hip replacements and HIV blood tests.
This Seminar will look at what to expect when the new regulation is implemented. Including: the transition period, Effect on Notified Bodies, Impact of the MDR on Quality Management Systems (QMS), technical documentation, clinical trial requirements, UDI and combination products.
Why you should attend:
Because the current Directive will be significantly altered and replaced by a Regulation which is legally binding on all Member States.
Areas Covered in the Session:
- The updated Regulation
- Implementation dates and transition
- Main changes and products affected
- Effect on medical device manufacturers
Who will benefit:
- Clinical Trial Managers
- Regulatory Affairs
- Medical Officers
Agenda:
Day 1 Schedule
Lecture 1 (90 Mins):
The new MDR main changes
- Main updates
- Transition periods
- Effect on medical device manufacturers
- Regulatory landscape
Lecture 2 (90 Mins):
Notified Bodies under the New MDR
- Effect on NBs
- When will NBs begin conformity assessment against the new Regulation?
- Main effect on medical device manufacturers
Lecture 3 (90 Mins):
Impact of the MDR on Quality Management Systems (QMS)
- When do I need to update my QMS?
- What main points need to be considered?
- Effect on medical device manufacturers
Lecture 4 (90 Mins):
Technical Documentation
- Class I and IIa devices
- Effect on class IIb devices
- Class III devices
CASE STUDY 1 - Including a walkthrough of expected outcomes for all case study exercises
Wrap up of day 1 & Q&A's
Day 2 Schedule
Lecture 1 (90 Mins):
Clinical aspects and testing
- Class I and IIa devices
- Effect on class IIb devices
- Class III devices
Lecture 2 (90 Mins):
Periodic Safety Update reports
- Content of PSUR
- Frequency
Lecture 3 (30 Mins):
Common Specification (CS)
Common Tech Specifications
Lecture 4 (90 Mins):
Combination Products
- Definitions
- Requirements
- Technical documentation
CASE STUDY 2 - Including a walkthrough of expected outcomes for all case study exercises
Wrap up of day 2 & Q&A's
Speaker:
Salma Michor
PhD, MSc, MBA, CMgr, RAC
Salma Michor is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH. She teaches regulatory affairs and clinical strategies at the University of Krems, Austria, and is an independent expert to the European Commission. She holds a PhD in thermal process engineering and an MSc in food and biotechnology from the University of Applied Life Sciences in Vienna, Austria; an MSc from King's College, University of London in food technology; and an MBA from Open University, and has earned the RAC (EU), CQA and is a Chartered manager.
Credits AvailableCourse "The New EU Medical Device regulation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
|
Frequently Asked
Questions
Payment Options
Bill Me/Invoice
Credit Card
Register
Online
Fax Form
Availability
Select a date from the list at the bottom of the page for specific information about that class.
Other Information
Seminar |
|